Author:
Li Lixia,Wang Yingjie,Zhao Ling,Ye Gang,Shi Fei,Li Yinglun,Zou Yuanfeng,Song Xu,Zhao Xinghong,Yin Zhongqiong,Wu Xueyuan,Li Wen,Tang Huaqiao
Funder
National Natural Science Foundation of China
Subject
Drug Discovery,Pharmacology
Reference49 articles.
1. Aberrant homing of mucosal T cells and extra-intestinal manifestations of inflammatory bowel disease;Adams;Nat. Rev. Immunol.,2006
2. The gut-liver axis in liver disease: pathophysiological basis for therapy;Albillos;J. Hepatol.,2020
3. Inulin exerts beneficial effects on non-alcoholic fatty liver disease via modulating gut microbiome and suppressing the lipopolysaccharide-toll-like receptor 4-mψ-nuclear factor-κb-nod-like receptor protein 3 pathway via gut-liver axis in mice;Bao;Front. Pharmacol.,2020
4. Gut-liver immune traffic: deciphering immune-pathogenesis to underpin translational therapy;Bozward;Front. Immunol.,2021
5. Growth faltering in rural Gambian infants is associated with impaired small intestinal barrier function, leading to endotoxemia and systemic inflammation;Campbell;J. Nutr.,2003
Cited by
6 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献